These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17953411)

  • 1. Targeted introduction of substances into the lymph nodes for endolymphatic therapy.
    Hirnle P
    Cancer Treat Res; 2007; 135():101-18. PubMed ID: 17953411
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug depots in lymph nodes: which carrier is most appropriate?
    Hirnle P
    J Microencapsul; 1991; 8(1):103-19. PubMed ID: 1880687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Participation of the lymphatic system in the metastasis of malignant tumors].
    Kraev AV; Levin IuM; Nikitina RG
    Vopr Onkol; 1977; 23(7):74-83. PubMed ID: 906400
    [No Abstract]   [Full Text] [Related]  

  • 4. [Endolymphatic therapy].
    Slusarczyk K; Ziółko E; Bucior J
    Pol Merkur Lekarski; 2001 Dec; 11(66):530-1. PubMed ID: 11899855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on intralymphatic-targeted hyaluronic acid-modified nanoliposome: influence of formulation factors on the lymphatic targeting.
    Tiantian Y; Wenji Z; Mingshuang S; Rui Y; Shuangshuang S; Yuling M; Jianhua Y; Xinggang Y; Shujun W; Weisan P
    Int J Pharm; 2014 Aug; 471(1-2):245-57. PubMed ID: 24858386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LyP-1-conjugated PEGylated liposomes: a carrier system for targeted therapy of lymphatic metastatic tumor.
    Yan Z; Wang F; Wen Z; Zhan C; Feng L; Liu Y; Wei X; Xie C; Lu W
    J Control Release; 2012 Jan; 157(1):118-25. PubMed ID: 21827801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The tumor pathomorphosis and status of the regional lymph nodes after the preoperative polychemotherapy of patients with vulvar cancer].
    Vorob'eva LI; Galakhin KA; Koval'chuk EN
    Lik Sprava; 1993 Jul; (8):87-9. PubMed ID: 8079489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anatomical prerequisites for endolymphatic radionuclide therapy].
    Kubik S
    Med Welt; 1974 Jun; 25(23):1011-6. PubMed ID: 4408560
    [No Abstract]   [Full Text] [Related]  

  • 9. Endolymphatic radionuclide therapy.
    Kubícek J; Vizda J; Urbanová E; Morávek F
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1979; 22(2):101-14. PubMed ID: 293870
    [No Abstract]   [Full Text] [Related]  

  • 10. [Targeting delivery of liposomal adriamycin by intra-lymphatic infusion].
    Feng B; Lang J; Li D
    Zhonghua Fu Chan Ke Za Zhi; 1997 Mar; 32(3):156-8. PubMed ID: 9596890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nano-chemotherapeutics: maximising lymphatic drug exposure to improve the treatment of lymph-metastatic cancers.
    Ryan GM; Kaminskas LM; Porter CJ
    J Control Release; 2014 Nov; 193():241-56. PubMed ID: 24801249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological findings in rabbit lymph nodes after endolymphatic injection of liposomes containing blue dye.
    Hirnle P
    J Pharm Pharmacol; 1991 Apr; 43(4):217-8. PubMed ID: 1712386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The functional morphology of the regional inguinal lymph nodes during the endolymphatic antibiotic therapy of patients with vascular diseases of the lower extremities].
    Kurkin AV; Idrisov BK; Nadyrov EA; Lokhvitskiĭ SV
    Arkh Anat Gistol Embriol; 1991; 101(9-10):18-20. PubMed ID: 1845509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New concept for the prevention and treatment of metastatic lymph nodes using chemotherapy administered via the lymphatic network.
    Kodama T; Matsuki D; Tada A; Takeda K; Mori S
    Sci Rep; 2016 Sep; 6():32506. PubMed ID: 27581921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of endolymphatic infusion of drugs in the treatment of malignant tumors].
    Rodovich VS; Dmitrenko SI
    Vrach Delo; 1971 Jul; 7():118-21. PubMed ID: 5123002
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lymphatic system changes after the endolymphatic administration of an oil-based solution of dibunol].
    Anan'ev VG; Kapuller LL; Eropkin PV; Shiiataia OK
    Vopr Onkol; 1984; 30(5):63-7. PubMed ID: 6328761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic changes in dog lymph nodes after endolymphatic application of bleomycin oil suspension.
    Hirnle P; Geppert M
    Lymphology; 1989 Jun; 22(2):100-2. PubMed ID: 2475726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph node metastases: importance of detection and treatment strategies.
    Obinu A; Gavini E; Rassu G; Maestri M; Bonferoni MC; Giunchedi P
    Expert Opin Drug Deliv; 2018 May; 15(5):459-467. PubMed ID: 29504430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endolymphatic chemotherapy in the treatment of diffuse forms of oncologic diseases in children].
    Anisimov LI; Dzasokhov SV; Durnov LA
    Pediatriia; 1975 Jun; (6):26-30. PubMed ID: 1228680
    [No Abstract]   [Full Text] [Related]  

  • 20. [Indication establishment and dosimetry in endolymphatic therapy with I-131 lipiodol].
    Winkel K; Becker J; Jahns E; Scheurlen H; Herzfeld U
    Strahlentherapie; 1967 Aug; 133(4):481-98. PubMed ID: 4298455
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.